Compound information
- Natural Products
- ZC1033472
- Molecular Formula
- C17H26N2O5S
- Molecular Weight
- 370.156242932 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-ethoxyphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H26N2O5S/c1-5-23-14-6-8-15(9-7-14)25(21,22)19-12-10-18(11-13-19)16(20)24-17(2,3)4/h6-9H,5,10-13H2,1-4H3
- InChI Key
- REQNBXHEDHQWHP-UHFFFAOYSA-N
- SMILES
- CCOc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000039320681
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 2.823 |
LogS | -3.905 | LogD | 3.577 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.142 | Pgp substrate | 0.014 |
HIA | 0.969 | F20 % | 0.989 |
F30 % | 0.959 | Caco-2 | -4.374 |
MDCK | -4.777 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.439 | PPB | 85.324 |
VD | 2.404 | Fu | 0.55 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.102 | CYP1A2 substrate | 0.472 |
CYP2A6 substrate | 0.719 | CYP2B6 substrate | 0.723 |
CYP2C19 inhibitor | 0.874 | CYP2C19 substrate | 0.789 |
CYP2C8 substrate | 0.587 | CYP2C9 inhibitor | 0.512 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.034 |
CYP2D6 substrate | 0.826 | CYP2E1 substrate | 0.841 |
CYP3A4 inhibitor | 0.18 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.331 | CL | 7.211 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.621 | Hepatotoxicity | 0.924 |
Mutagenicity | 0.075 | Rat Oral Acute Toxicity | 0.201 |
FDAMDD | 0.025 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.747 | Eye Corrosion | 0.002 |
Eye Irritation | 0.013 | Respiratory Toxicity | 0.459 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.58 | IGC50 | 3.341 |
LC50FM | 2.794 | LC50DM | 2.313 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.255 | NR-AR-LBD | 0.275 |
NR-AhR | 0.058 | NR-Aromatase | 0.466 |
NR-ER | 0.272 | NR-ER-LBD | 0.414 |
NR-PPAR-gamma | 0.127 | SR-ARE | 0.78 |
SR-ATAD5 | 0.383 | SR-HSE | 0.084 |
SR-MMP | 0.041 | SR-p53 | 0.028 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.